Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

Recruiting

2 1 1
Investigated Drugs:
- VERT-002
Evaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial

Recruiting

2 1 1 1
Investigated Drugs:
Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated Drugs:
- Pembrolizumab
+10
Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated Drugs:
+3
A study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+6
Phase 2 Study of Rinatabart Sesutecan with PEGFILGRASTIM in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Recruiting

2 1 1 1
Investigated Drugs:
- HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST FOLR1 CONJUGATED TO 1-[(2R,3R,4R,5S,52S)-1,2,3,4,5-PENTAHYDROXY-52-{[(2S)-1-{[(2S)-5-CARBAMOYLAMINO-1-OXO-1-{3-[({[(1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12HBENZO[DE]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-1-YL]CARBAMOYL}OXY)METHYL]ANILINO}PENTAN-2-YL]AMINO}-3-METHYL-1-OXOBUTAN-2-YL]CARBAMOYL}-7-[(2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL]-46,54-DIOXO10,13,16,19,22,25,28,31,34,37,40,43-DODECAOXA-7,47,53-TRIAZANONAPENTACONTAN-59-YL]-2,5-DIOXOPYRROLIDIN-3-YL
+2
A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Recruiting

3 1 1
Investigated Drugs:
+2
A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer

Recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- BNT327
A study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies